Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Intrexon to acquire Oxitec

The US synthetic biology company, Intrexon Corporation (Germantown, Maryland), has agreed to acquire the UK biotechnology company, Oxitec (Abingdon, Oxfordshire). Oxitec employs RIDL (release of insects carrying a dominant lethal gene) technology to control insect pests. It has focused on genetically modified dengue-carrying mosquitoes, Mediterranean fruit flies, olive flies, diamondback moths, pink bollworms and tomato leaf miners.  Intrexon intends to integrate its synthetic biology platform to advance Oxitec's existing initiatives on disease vectors and agricultural pests. Oxitec's shareholders will receive approximately $80 million in Intrexon common stock and $80 million in cash. The acquisition is expected to be completed later this year.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts